View printer-friendly version |
« Back |
September 19, 2000 3:31 p.m. |
![]() |
Teva Receives First Generic Approval for Amoxicillin 500 and 875 mg Tablets |
![]() |
![]() |
Jerusalem, Israel, September 19, 2000 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has received from the U.S. FDA final approval to manufacture and market Amoxicillin 500 and 875 mg Tablets, intended for twice-daily dosage.
|